Hello, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? Perhaps a cup or two of stimulation is in order. Today, we are quaffing stroopwafel, for those who like to track this sort of thing, And by the way, a prescription is not required. So feel free to indulge as you attack the laundry list of meetings and deadlines that await. Meanwhile, we have once again assembled a list of tidbits for you to peruse and help you on your way. Hope you have a smashing day and, as always, do drop us a line when you hear something interesting. …
Several hundred GlaxoSmithKline workers have voted to go on strike after rejecting a below-inflation pay raise, setting the stage for an industrial battle unusual in the pharmaceutical industry, The Financial Times tells us. Unite, the union representing the workers at manufacturing sites across the U.K., said the strike would be the first in the drugmaker’s history. Unite members voted 86% in favor of strike action. GSK said it offered a pay increase of 4%, but Unite said that was conditional on the union recommending it to its members, which it was not willing to do. The company’s first offer was 2.75%.
Poland will not take or pay for more doses of Covid-19 vaccine under a European Union supply contract, setting the stage for a legal battle with manufacturers, Reuters reports. Poland, along with other EU members, has been receiving Covid-19 vaccines during the coronavirus pandemic under supply contracts agreed between the European Commission and vaccine makers. However, the country has seen lower vaccine uptake than most of the European Union and has surplus vaccine stock, part of which it has sold or donated to other countries. But Poland cannot directly terminate the contract because direct parties are the European Commission and manufacturers.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
